These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10719059)
1. Late effects of anthracycline therapy in childhood on signal-averaged ECG parameters. Mladosievicova B; Foltinova A; Petrasova H; Hulin I Int J Mol Med; 2000 Apr; 5(4):411-4. PubMed ID: 10719059 [TBL] [Abstract][Full Text] [Related]
2. Frequency-domain analysis of the QRS complex after treatment of childhood cancer with anthracycline cytostatics. Mladosievicova B; Foltinova A; Luptak I; Petrasova H; Hulin I Pediatr Cardiol; 2001; 22(6):478-82. PubMed ID: 11894149 [TBL] [Abstract][Full Text] [Related]
3. [Frequency analysis of the QRS complex: a new method of detecting development of myocardial damage after anthracycline cytostatics]. Mladosievicova B; Foltinova A; Paulovic P; Petrasova H; Hulin I Bratisl Lek Listy; 2000; 101(7):409-11. PubMed ID: 11059111 [TBL] [Abstract][Full Text] [Related]
4. Signal-averaged ECG in patients after anthracycline therapy for childhood cancer. Mladosievicová B; Foltinová A; Bernadic M; Hubka P; Petrásová H; Hulín I Neoplasma; 1998; 45(1):40-5. PubMed ID: 9605001 [TBL] [Abstract][Full Text] [Related]
5. [High-resolution electrocardiography in monitoring myocardial damage after therapy with anthracyclines in children]. Mladosievicová B; Foltinová A; Bernadic M; Petrásová H; Hulín I Bratisl Lek Listy; 1996 May; 97(5):289-97. PubMed ID: 8705327 [TBL] [Abstract][Full Text] [Related]
6. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography. Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752 [TBL] [Abstract][Full Text] [Related]
7. Late cardiotoxicity after treatment for a malignant bone tumor. Postma A; Bink-Boelkens MT; Beaufort-Krol GC; Kengen RA; Elzenga NJ; Schasfoort-van Leeuwen MJ; Schraffordt koops H; Kamps WA Med Pediatr Oncol; 1996 Apr; 26(4):230-7. PubMed ID: 8600333 [TBL] [Abstract][Full Text] [Related]
8. Frequency-domain analysis of the signal-averaged electrocardiogram in hematological malignancies survivors. Urbanova D; Urban L; Mikuskova E; Klincova M; Mladosievicova B Bratisl Lek Listy; 2010; 111(3):144-9. PubMed ID: 20437824 [TBL] [Abstract][Full Text] [Related]
9. Cardiac functions by myocardial performance index and QT dispersion in survivors of childhood lymphoblastic leukaemia. Gulen H; Kazanci E; Mese T; Uzunkaya D; Erbay A; Tavli V; Vergin C Minerva Pediatr; 2007 Apr; 59(2):107-13. PubMed ID: 17404560 [TBL] [Abstract][Full Text] [Related]
10. Anthracycline dose in childhood acute lymphoblastic leukemia: issues of early survival versus late cardiotoxicity. Sorensen K; Levitt G; Bull C; Chessells J; Sullivan I J Clin Oncol; 1997 Jan; 15(1):61-8. PubMed ID: 8996125 [TBL] [Abstract][Full Text] [Related]
11. Late cardiac damage of anthracycline therapy for acute lymphoblastic leukemia in childhood. Prestor VV; Rakovec P; Kozelj M; Jereb B Pediatr Hematol Oncol; 2000; 17(7):527-40. PubMed ID: 11033728 [TBL] [Abstract][Full Text] [Related]
12. Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer. Feijen EA; Leisenring WM; Stratton KL; Ness KK; van der Pal HJ; Caron HN; Armstrong GT; Green DM; Hudson MM; Oeffinger KC; Robison LL; Stovall M; Kremer LC; Chow EJ J Clin Oncol; 2015 Nov; 33(32):3774-80. PubMed ID: 26304888 [TBL] [Abstract][Full Text] [Related]
13. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study. Sorensen K; Levitt GA; Bull C; Dorup I; Sullivan ID Cancer; 2003 Apr; 97(8):1991-8. PubMed ID: 12673729 [TBL] [Abstract][Full Text] [Related]
14. [Long-term study of anthracycline-induced cardiomyopathy in children and adolescents]. Koch H; Schmitz L; Brockmeier K; Hartmann R; Bein G; Henze G Klin Padiatr; 1991; 203(4):262-7. PubMed ID: 1942932 [TBL] [Abstract][Full Text] [Related]
15. [Cardiotoxicity of anthracycline cytostatic agents--a proposal for routine monitoring and supportive therapy]. Svojgrová M; Slechtová J; Hůla J Vnitr Lek; 1991 Feb; 37(2):151-9. PubMed ID: 2021075 [TBL] [Abstract][Full Text] [Related]
16. Cardiac function in Wilms' tumor survivors. Sorensen K; Levitt G; Sebag-Montefiore D; Bull C; Sullivan I J Clin Oncol; 1995 Jul; 13(7):1546-56. PubMed ID: 7602343 [TBL] [Abstract][Full Text] [Related]
17. Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines? Pourier MS; Mavinkurve-Groothuis AM; Loonen J; Bökkerink JP; Roeleveld N; Beer G; Bellersen L; Kapusta L Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27654133 [TBL] [Abstract][Full Text] [Related]
18. The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer. Elbl L; Hrstkova H; Chaloupka V Eur J Pediatr; 2003 Oct; 162(10):690-6. PubMed ID: 12905011 [TBL] [Abstract][Full Text] [Related]
19. Detection of early anthracycline-induced cardiotoxicity in childhood cancer with dobutamine stress echocardiography. Lenk MK; Zeybek C; Okutan V; Ozcan O; Gökçay E Turk J Pediatr; 1998; 40(3):373-83. PubMed ID: 9763901 [TBL] [Abstract][Full Text] [Related]
20. Indium-111-antimyosin scintigraphy in the early detection of heart damage after anthracycline therapy in children. Kremer LC; Tiel-van Buul MM; Ubbink MC; Offringa M; Ottenkamp J; Olmos RV; Voûte PA J Clin Oncol; 1999 Apr; 17(4):1208. PubMed ID: 10561180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]